Bringing Clinical Trials Closer to Patients within the Care Setting
Embedding clinical trials into hospitals and healthcare systems can lead to better health outcomes, higher rates of clinical trial participation, lower cost of care and more satisfied patients.
The CRAACO® conference addresses how healthcare systems, hospitals and pharma can work together to integrate clinical trials with clinical care and bring more patients the option of trial participation.
Key Topics for 2025
- Building and optimizing trial infrastructure, billing systems and staffing for hospitals and healthcare systems to become research-ready
- Helping pharma work better with hospitals and health systems to bridge the gap between research and care
- How to make the business case to hospital/healthcare executives for integrating clinical care and clinical research
- Success examples of getting more patients access to the option of clinical research in underrepresented communities, community care and rural/frontier settings
- Regulatory and policy updates impacting clinical research as a care option
KEYNOTE
Turning Clinical Environments into Learning Health Systems to Bridge the Gap Between Care and Research
Laura Esserman, MD
UCSF Carol Franc Buck Breast Care Center
KEYNOTE
How to Develop a Clinical Research Program within a Community Cancer Center
Brian Slomovitz, MD
Mount Sinai Medical Center Miami Beach
Creating an Infrastructure for Pharma and Healthcare to Provide Greater Patient Access to Clinical Trials
"The intersection between pharma and the health system really helps to understand the next questions to start addressing."
Emily Ray Ko, MD, PhD, Assistant Professor, Duke Department of Medicine Hospitalist Medicine, Duke Regional Hospital
4 Benefits of CRAACO for:
Health Systems
- Provide patients with more options by being on the cutting-edge of research
- Learn how to structure clinical trials around the continuity of care
- Build or optimize the capacity to become research-ready partners to industry
- Attract physicians, retain patients and develop the next generation of clinical researchers
Pharma
- Understand the current healthcare and hospital ecosystem to become better partners in research
- Partner with more sites beyond AMCs to get patients more access to clinical trials
- Reduce the gap of health inequity and reach diverse patient populations
- Greater access to real-world data to help pair the right patient to a clinical trial
Featured Speakers
Matching Patients to Trials Using AI and Scaling up EHR Data Collection
Nadir Ammour
Sanofi
How Pharma Can Collaborate with Multi-Location Health Systems
Adam Kinsey
Merck
Building the Research Infrastructure in the Community Hospital
Dr Emily Ray Ko
Duke Regional Hospital
How Health Systems Can Make Trials More Productive and Effective
Donna O'Brien
Manatt Health
Getting the Option of Clinical Trials into Frontier Community Clinics
Dr Elizabeth Johnson
Montana State University
Clinical Trials and the Impact on Cost and Performance for Cancer Centers
Dr Maureen Canavan
Yale
A Decade of Clinical Reserch as a Care Option - And Where It's Going Next
Dr Christina Brennan
Northwell Health
Leveraging Local Health Care Providers to Bring Trials to Rural Communities
Dr J. Kaitlin Morrison
UNC-Chapel Hill
5 Goals of CRAACO
1. Chart a path towards more fully integrating clinical trials into care settings by bringing together key stakeholders: health systems, pharma, patient advocacy, payors, regulators and innovators
2. Demonstrate practical examples, strategies and success stories from health systems that illustrate fit-for-purpose approaches
3. Aid pharma navigating the intersection points of research and care
4. Demonstrate tools, services and vendors specifically geared towards allowing for the safe and efficient integration of clinical trials into health systems
5. Identify ways to reduce the burdens of participation for clinicians, research investigators and patients and make research look more like care
2025 Sponsors
.png)
"It was powerful to see so many people dedicated to improving the clinical trial process—not just for the sponsors and trial sites but, most importantly, for the patients and their families."
Sabina Kineen, Patient Advocate